Necrotizing pneumonia caused by refractory Mycoplasma pneumonia pneumonia in children
- PMID: 29948966
- DOI: 10.1007/s12519-018-0162-6
Necrotizing pneumonia caused by refractory Mycoplasma pneumonia pneumonia in children
Abstract
Background: To investigate the clinical features of necrotizing pneumonia (NP) caused by refractory Mycoplasma pneumoniae pneumonia (RMPP).
Methods: A retrospective observational study was carried out in patients with NP caused by RMPP who were admitted to our hospital from January 2008 to December 2015, and the clinical manifestations, laboratory data, imaging performances, hospital courses and outcomes were analyzed.
Results: Twenty-five patients with NP caused by RMPP were collected, with a median age of 5.1 (4.0-7.9) years. The mean duration of fever and hospital stay was 21.0 ± 8.9 and 19.9 ± 9.9 days, respectively. The levels of lactate dehydrogenase (LDH), C-reactive protein, interleukin (IL)-6, IL-10 and interferon-gamma were elevated. Meanwhile, the pleural fluid cell count, LDH and protein were also increased. 80.0% of the patients had pleural effusion; and a high incidence of lobar atelectasis and pulmonary consolidation was found the patients. The mean duration from the onset of symptoms to the discovery of necrotic lesions was 21.0 ± 6.9 days. 80.0% of the patients were administrated corticosteroids, and bronchoalveolar lavage was extracted separately from all patients. Of the 20 patients who presented with pleural effusion, 11 underwent thoracocentesis alone and 2 underwent chest drainage. All patients received prolonged courses of antibiotics (32.2 ± 8.7 days). All patients were dischaged home and recovered without surgical intervention; and chest lesions were resolved or only minimal residual fibrotic changes were residual within 3.0 (2.0-6.0) months.
Conclusions: Necrotizing pneumonia caused by RMPP is severe, however, self-limiting and reversible. Good outcomes can be achieved with appropriate management.
Keywords: Children; Mycoplasma pneumoniae; Necrotizing pneumonia; Refractory.
Similar articles
-
[Comparative analysis of clinical characteristics and prognosis between bacterial necrotizing pneumonia and Mycoplasma pneumoniae necrotizing pneumonia in children].Zhonghua Er Ke Za Zhi. 2019 Aug 2;57(8):625-630. doi: 10.3760/cma.j.issn.0578-1310.2019.08.011. Zhonghua Er Ke Za Zhi. 2019. PMID: 31352749 Chinese.
-
Independent predictors for longer radiographic resolution in patients with refractory Mycoplasma pneumoniae pneumonia: a prospective cohort study.BMJ Open. 2018 Dec 18;8(12):e023719. doi: 10.1136/bmjopen-2018-023719. BMJ Open. 2018. PMID: 30567824 Free PMC article.
-
[Chest CT features and outcome of necrotizing pneumonia caused by Mycoplasma pneumoniae in children (report of 30 cases)].Zhonghua Er Ke Za Zhi. 2013 Mar;51(3):211-5. Zhonghua Er Ke Za Zhi. 2013. PMID: 23751584 Chinese.
-
[Analysis of 3 cases with Mycoplasma pneumoniae-associated hemophagocytic syndrome and review of literature].Zhonghua Er Ke Za Zhi. 2014 Oct;52(10):792-6. Zhonghua Er Ke Za Zhi. 2014. PMID: 25537549 Review. Chinese.
-
Refractory Mycoplasma Pneumonia in Children: A Systematic Review and Meta-analysis of Laboratory Features and Predictors.J Immunol Res. 2022 Jun 26;2022:9227838. doi: 10.1155/2022/9227838. eCollection 2022. J Immunol Res. 2022. PMID: 35795531 Free PMC article.
Cited by
-
Clinical Characteristics of Necrotizing Pneumonia Caused by Different Pathogens.Infect Drug Resist. 2023 Jun 14;16:3777-3786. doi: 10.2147/IDR.S419294. eCollection 2023. Infect Drug Resist. 2023. PMID: 37337573 Free PMC article.
-
Development and validation of a nomogram for predicting necrotizing pneumonia in children with refractory Mycoplasma pneumoniae pneumonia.Ital J Pediatr. 2025 May 21;51(1):150. doi: 10.1186/s13052-025-02006-7. Ital J Pediatr. 2025. PMID: 40399899 Free PMC article.
-
Clinical effect of reduning combined with gamma globulin treatment on symptom improvement serum levels of IL-6, 25-(OH)D and LDH in children with severe mycoplasma pneumonia.Pak J Med Sci. 2022 Mar-Apr;38(4Part-II):826-832. doi: 10.12669/pjms.38.4.5203. Pak J Med Sci. 2022. PMID: 35634590 Free PMC article.
-
Pediatric Critical Illness Score, Clinical Characteristics and Comprehensive Treatment of Children with Severe Mycoplasma Pneumoniae Pneumonia.Front Surg. 2022 May 25;9:897550. doi: 10.3389/fsurg.2022.897550. eCollection 2022. Front Surg. 2022. PMID: 35693303 Free PMC article.
-
[Analysis of clinical features and risk factors of necrotizing pneumonia in children].Beijing Da Xue Xue Bao Yi Xue Ban. 2022 Jun 18;54(3):541-547. doi: 10.19723/j.issn.1671-167X.2022.03.021. Beijing Da Xue Xue Bao Yi Xue Ban. 2022. PMID: 35701133 Free PMC article. Chinese.
References
Publication types
MeSH terms
Substances
Grants and funding
- 2015C33127/Science & Technology Bueau of Zhejiang Province/International
- LY17H100004/Zhejiang Province Natural Science Fundation of China/International
- LY18H100002/Zhejiang Province Natural Science Fundation of China/International
- 2018268955/the key projects of Zhejiang Medicine & Health Research Fund/International
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous